Sutro Biopharma (STRO)
$2.12 -$0.07 (-3.18%) 11:20 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$174.81M -
Day's Range
$2.08 - $2.23 -
Volume
1,365,928 -
52 Week Low / High
$2.08 - $6.13 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
STRO's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 7
- Strong Buy
- 3
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $16.89
- Target Price
Company News
-
Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC — Jan 4th, 2024
Sutro Biopharma, Inc. Ovarian cancer data supports registration-enabling trial of luvelta for women with platinum-resistant ovarian cancer Potential benefit to 8 out of 10 platinum-resistant ovarian cancer patients, including addressing unmet need in patients with low-medium FolRα expre...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$